首页> 美国卫生研究院文献>Springer Open Choice >A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

【2h】

A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

机译：一项II期随机研究比较奥沙利铂加5-氟尿嘧啶和亚叶酸（FOLFOX4）与奥沙利铂加拉替曲定（TOMOX）作为晚期大肠癌一线化疗的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionThe aim of this study was to compare TOMOX versus FOLFOX4 as first-line treatment of advanced colorectal cancer (CRC).

机译：简介本研究的目的是比较TOMOX和FOLFOX4作为晚期大肠癌（CRC）的一线治疗方法。

著录项

期刊名称 Springer Open Choice
作者
Cristina Gravalos; Antonieta Salut; Carlos García-Girón; Rocío García-Carbonero; Ana Isabel León; Isabel Sevilla; Joan Maurel; Beatriz Esteban; Eduardo García-Rico; Adolfo Murias; Hernán Cortés-Funes;
展开▼
作者单位

展开▼
年(卷),期 -1(14),8
年度 -1
页码 606–612
总页数 7
原文格式 PDF
正文语种
中图分类外科学;
关键词
Colorectal cancer Raltitrexed Oxaliplatin Fluorouracil;

机译：大肠癌;拉替曲塞;奥沙利铂;氟尿嘧啶;

相似文献

外文文献
中文文献
专利

1. A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer [J] . GravalosC., SalutA., García-GircónC., Clinical & translational oncology : . 2012,第8期

机译：一项II期随机研究比较奥沙利铂加5-氟尿嘧啶和亚叶酸（FOLFOX4）与奥沙利铂加raltitrexed（TOMOX）作为晚期大肠癌一线化疗的比较
2. A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer [J] . Cristina Gravalos, Antonieta Salut, Carlos García-Girón, Clinical and Translational Oncology . 2012,第8期

机译：一项II期随机研究比较奥沙利铂加5-氟尿嘧啶和亚叶酸（FOLFOX4）与奥沙利铂加拉替曲定（TOMOX）作为晚期大肠癌一线化疗的比较
3. Randomized, Phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) Versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The PRIME study [J] . DouillardJ.-Y., SienaS., CassidyJ., Journal of Clinical Oncology . 2010,第31期

机译：帕尼单抗与氟尿嘧啶，亚叶酸和奥沙利铂（FOLFOX4）输注的随机，III期试验与单独使用FOLFOX4作为先前未经治疗的转移性结直肠癌患者的一线治疗：PRIME研究
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer [O] . Dimitrios Pectasides, Vasilios Karavasilis, George Papaxoinis, 2015

机译：III期临床试验比较卡培他滨与奥沙利铂（CAPOX）组合与5-氟尿嘧啶亚叶酸和奥沙利铂（改良的FOLFOX6）组合作为辅助治疗手术后高危II期或III期结直肠癌患者的临床试验
6. A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer [O] . Cristina Gravalos, Antonieta Salut, Carlos García-Girón, 2012

机译：一项II期随机研究比较奥沙利铂加5-氟尿嘧啶和亚叶酸（FOLFOX4）与奥沙利铂加拉替曲定（TOMOX）作为晚期大肠癌一线化疗的比较

A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

摘要

著录项

相似文献

相关主题

期刊订阅